New South Wales, Australia

Sarah Jane Richardson

USPTO Granted Patents = 3 


 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2016-2025

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Sarah Jane Richardson

Introduction

Sarah Jane Richardson is a notable inventor based in New South Wales, Australia. She has made significant contributions to the field of pharmaceutical compositions, particularly focusing on injectable formulations. With a total of 3 patents to her name, her work has garnered attention for its innovative approaches to drug delivery.

Latest Patents

Richardson's latest patents include injectable pharmaceutical compositions that comprise a cyclodextrin, a hydrophobic drug, a co-solvent, and a preservative. These compositions are designed to create water-soluble complexes that effectively preserve the integrity of the drug. The formulations meet the stringent requirements set forth by the European Pharmacopoeia 2011 and the United States Pharmacopeia 2011 for antimicrobial effectiveness, ensuring safety and efficacy for injectable products.

Career Highlights

Throughout her career, Sarah Jane Richardson has worked with reputable companies such as Jurox Pty Ltd and Zoetis Services LLC. Her experience in these organizations has allowed her to refine her expertise in pharmaceutical innovations and contribute to advancements in drug formulation.

Collaborations

Richardson has collaborated with professionals like Kirby Shawn Pasloske and Amanda Aileen Willis, further enhancing her work in the pharmaceutical field. These collaborations have played a crucial role in the development of her patented technologies.

Conclusion

Sarah Jane Richardson's contributions to pharmaceutical innovations highlight her dedication to improving drug delivery systems. Her patents reflect a commitment to safety and efficacy in injectable products, making her a significant figure in the field of pharmaceutical sciences.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…